top of page

PHARMAECONOMICA
AI-Driven Drug Discovery

Harnessing our expertise in AI/ML, Computational Chemistry, and Peptide Science, we discover and optimize active, specific, non-toxic, and patentable small molecules, delivering superior drug candidates in a faster and more cost-effective manner.

We are Increasing Drug Discovery Productivity via AI/ML and Biophysics.

Comparison traditional vs Insilico Drug Discovery-process updates-02.jpg
alzheimer pareja 1.png

We have discovered and optimized two patentable, potent, selective, and brain-specific Butyrylcholinesterase Inhibitors (BChE-Is) with potential applications in late-stage Alzheimer’s - the main cause of Dementia. These inhibitors hold promise as symptomatic drugs, disease-modifying agents with neuroprotective functions, and potential biomarkers

Drug discovery from extensive chemical space -
Shooting on Targets!

PREDIT: Our Proprietary Discovery Platform

bottom of page